Foley KM, Sundaresan N: Management of cancer pain. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of oncology. Philadelphia: JB Lippincott Company, 1985:1940-1961
3.
Payne R: Definitions and epidemiology of cancer pain. In: Wittes RE, ed. Manual of oncologic therapeutics 1989/1990. Philadelphia: JB Lippincott Company, 1989:469-489
Magni G, Conlon P, Arsie D: Tricycic antidepressants in the treatment of cancer pain: A review. Pharmacopsychiat1987;20: 160-164
6.
Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J: Amitriptyline versus placebo in postherpetic neuralgia. Neurology NY)1982;32:671-673
7.
Forrest WH, Brown BW, Brown CR, Defalque R, Gold M, Gordon HE, James KE, Katz J, Mahler DL, Schroff P, Teutsch G: Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med1977;296:712-715
8.
Joshi JH, deJongh CA, Schnaper N, Former CLWiemik PH: Amphetamine therapy for enhancing the comfort of terminally ill patients pts) with cancer. Proc Am Soc Clin Oncol1982;1:55-55
9.
Bruera E, Carraro S. Roca E, Barugel M, Chacon R: Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients. Cancer Treat Rep1986;70:295-298
10.
Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald RN: Methyl phenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep1987;71:67-70
